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Background: Pulmonary vein isolation (PVI) via catheter ablation has been shown to be a highly effective
treatment option for patients with symptomatic paroxysmal atrial ﬁbrillation (AF). The recurrence of AF
within 3 months after PVI is not considered to be the result of ablation procedure failure, because early
recurrence of AF is not always associated with late recurrence. We examined the usefulness of an external
loop recorder with an auto-trigger function (ELR-AUTO) for the detection of atrial ﬁbrillation following PVI to
characterize early recurrence and to determine the implications of AF occurrence within 3 months after PVI.
Methods: Fifty-three consecutive symptomatic patients with paroxysmal AF (age 61.6712.6 years, 77%
male) who underwent PVI and were ﬁtted with ELR-AUTO for 772.0 days within 3 months after PVI were
enrolled in this study.
Results: Of the 33 (62.2%) patients who did not have AF recurrence within 3 months after PVI, only 1 patient
experienced AF recurrence at 12 months. Seven (35%) of the 20 patients who experienced AF within
3 months of PVI experienced symptomatic AF recurrence at 12 months. The sensitivity, speciﬁcity, positive
predictive value, and negative predictive value of early AF recurrence for late recurrence were 87.5%, 71.1%,
35.0%, and 96.9%, respectively.
Conclusions: AF recurrence measured by ELR-AUTO within 3 months after PVI can predict the late recurrence
of AF. Freedom from AF in the ﬁrst 3 months following ablation signiﬁcantly predicts long-term AF freedom.
ELR-AUTO is useful for the detection of symptomatic and asymptomatic AF.
& 2014 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Pulmonary vein isolation (PVI) via catheter ablation has been
shown to be a highly effective treatment option for patients with
symptomatic paroxysmal atrial ﬁbrillation (AF). The recurrence of
AF within 3 months after PVI is common and is not considered to
be the result of catheter ablation procedure failure, because the
early recurrence of AF in this period is not always associated with
late recurrence of AF. Therefore, this period is referred to as
the “blanking period” [1,2]. However, the clinical signiﬁcance of
early recurrence is controversial because most studies determine
AF recurrence on the basis of symptoms [3]. The incidence of
symptomatic and asymptomatic AF recurrence within 3 months
after PVI has not been well investigated.
The SpiderFlash-t device (Sorin, France) is an external loop
recorder with an auto-trigger function (ELR-AUTO) that detects
and records any arrhythmia automatically. We examined the
usefulness of ELR-AUTO for the detection of AF within 3 months
after PVI to characterize early recurrence and to determine the
implications of AF occurrence within 3 months.
2. Material and methods
2.1. Study subjects
Fifty-three consecutive patients who underwent PVI at our
hospital between April and December, 2012 and were monitored
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with an ELR-AUTO within 3 months after catheter ablation were
enrolled in this study. The patients had highly symptomatic AF
that was refractory to drugs. Medical histories were obtained by
reviewing the patients' medical records for ECGs and Holter
recordings of AF episodes. Written informed consent was obtained
from all subjects before catheter ablation was performed.
2.2. Catheter ablation
Warfarin was discontinued 3 days before the procedure. The
PVI catheter ablation procedure was performed with electrode
catheters placed in the high right atrium, coronary sinus, and His
bundle region. The left atrium (LA) was approached via an atrial
septal puncture under the guidance of intravascular ultrasound.
Heparin was then administered to maintain an activated clotting
time of 350 s. Three-dimensional mapping was performed using
either a CARTO (Biosense Webster, Diamond Bar, CA) or NavX (St.
Jude Medical, St. Paul, MN) system, and then a LASSO (Biosense
Webster) catheter was placed in the pulmonary veins (PVs). The
ablation applications were delivered with an irrigation catheter at
a power setting of 3035 W on the anterior wall and 2025 W on the
posterior wall. The endpoint of the ablation was bidirectional
block at the PV–LA antrum. The procedure was considered
complete when no arrhythmia induction occurred during pro-
grammed stimulation (cycle length 200 ms).
2.3. Post-ablation evaluation
For the clinical follow-up, after undergoing ablation, the
patients were ﬁtted with an ELR-AUTO for 1–2 weeks within the
3 months following the ablation procedure. Atrial ﬁbrillation
burden within 3 months after ablation was deﬁned as an early
AF episode lasting for 60 s, with or without symptoms. Sympto-
matic AF was deﬁned as AF with related symptoms, such as
palpitations or chest discomfort.
The patients underwent an electrocardiogram (ECG) recording
at the hospital every month during the 3 months after the ablation
procedure. Late recurrence, deﬁned as AF detected by any method
12 months after ablation, was evaluated using a 12-lead ECG,
Holter ECG, or ELR-AUTO.
2.4. External loop recorder
Regarding the ﬁtting of the ELR-AUTO, the medical technician
only installed the device on the ﬁrst day and instructed the
patients on how to attach the device thereafter. From the second
day forward, the patients attached the device on their own. The
patients placed 1 cathode (white) and 2 anode (red and brown)
patches on their body surface. The frequency characteristics of the
ECG recordings ranged from 0.05 to 80 Hz. The dynamic range of
the input was 716 mV to 7300 mV. The carrier frequency was
200 Hz, and the resolution was 10 μV.
The automatic detection of arrhythmias allowed the ECG loop
reorder to record the 2 min after an event and the 4 min before an
event when the patient noticed a symptom and pressed a button
on the device. The settings of the automatic detection function of
the ELR-AUTO are shown in Table 1. In the case of a supraven-
tricular tachycardia at a rate of 160 beats/min lasting for 10 s or
more, the 60 s before and after the event were recorded. When an
RR-interval irregularity was maintained for 60 s, the 60 s before
and 120 s after the irregularity were recorded. Premature atrial
contractions (PAC) occurring within the ﬁrst 75% of the RR interval
were recorded. If a ventricular tachycardia faster than 140 beats/
min and lasting more than 8 s occurred, the 60 s before and after it
were recorded. Premature ventricular contractions (PVC) were
recorded if they occurred within the ﬁrst 85% of the RR interval.
For bradycardia of 40 beats/min or less, lasting for 20 s, the 60 s
before and after it were recorded. For any pause longer than
3000 ms, the 10 s before and after it were recorded. In the case of
an RR interval of 1000 ms or more during block, the 10 s before
and after it were recorded. The device was set to record the 4 min
before and 2 min after any symptomatic events.
2.5. Statistical analysis
Continuous variables are expressed as mean7standard devia-
tion. A p-value o0.05 was considered to indicate a signiﬁcant
difference. For the statistical analyses, JMP version 10.0 software
(SAS Institute, Cary, USA) was used.
3. Results
3.1. Patient characteristics
The patient characteristics are shown in Table 2. There were 53
subjects, including 41 male and 12 female patients, with a mean age
of 61.6712.6 years and a mean disease duration of 4.674.4 years.
Echocardiography ﬁndings revealed that the mean left atrial diameter
was 43.676.1 mm and the mean ejection fraction was 61.275.9%.
Table 1
Settings for the ELA-AUTO's automatic detection function.
Disorder Threshold Minimum
duration (s)
Time before
(s)
Time after
(s)
SV tachycardia 160 10 60 60
Irregular RR 60 60 120
%SV 75
Ventricular
tachycardia
140 8 60 60
%V 85
Bradycardia 40 20 60 60
Pause 3000 10 10
Missed beats 1000 10 10
SV tachycardia: supraventricular tachycardia.
Table 2
Patient characteristics.
Total
Patients (male/female) (n) 53 (41/12)
Age (years) 61.6712.6
Disease duration (years) 4.674.4
Echocardiography
Left atrial diameter (mm) 43.676.1
Left ventricular ejection fraction (%) 61.275.9
DcT (ms) 218.2760.4
E/e0 7.276.2
Antiarrhythmic drug (n) 27
Underlying disease
HT (n) 23
DM (n) 5
Dyslipidemia (n) 16
CHF (n) 9
DcT: deceleration time, E/e0: ratio between velocities of the
E and A waves on Doppler transmitral ﬂow, HT: hyperten-
sion, DM: diabetes mellitus, HL: hyperlipidemia, and CHF:
congestive heart failure.
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3.2. Catheter ablation
Complete isolation was achieved in 51 patients with an
incomplete isolation in 2 patients. In 2 patients, we were able to
conﬁrm a unidirectional block, but this was left untreated so as not
to prolong the procedure time excessively. When AF was induced
by programmed atrial stimulation after PVI, linear ablation of the
LA roof and mitral isthmus was performed (n¼6). When common
atrial ﬂutter was induced by programmed atrial stimulation, linear
ablation of the cavotricuspid isthmus was performed (n¼18).
3.3. AF within 3 months after ablation
AF episodes were recorded by the ELR-AUTO in 20 (37.7%) of the
53 patients. There was no signiﬁcant difference in the incidence of
AF with regard to gender, age, echocardiographic ﬁndings, oral
medications, or underlying disease. Ten of the 20 patients (50%)
who experienced AF had both symptomatic and asymptomatic AF,
whereas 10 (50%) had only asymptomatic AF. Table 3 shows details
of the group with both symptomatic and asymptomatic recurrent
AF (n¼10) and the group with only asymptomatic recurrent AF
(n¼10) among the patients in whom AF was detected by ELR-AUTO
monitoring. There was no signiﬁcant difference between the
2 groups with regard to gender, age, echocardiographic ﬁndings,
oral medications, or underlying disease. However, patients with
symptomatic AF had a longer history of atrial arrhythmia than
patients with asymptomatic AF (6.173.6 vs. 2.172.1 years,
po0.01). In addition, the E/e0 ratio (between the velocities of the
E and A waves on Doppler transmitral ﬂow) was higher in patients
with symptomatic AF than in patients with asymptomatic AF
(7.071.1 vs. 5.571.0, po0.01).
3.4. Events for which patients activated the ELR-AUTO
The patients activated the ELR-AUTO for a total of 393 events.
Fig. 1 shows the ECG classiﬁcations of those events. Of the 393
events, 177 (46%) showed normal sinus rhythm (NSR), 88 (22%)
were PACs, 47 (12%) were AF, 37 (9%) were PVCs, and 43 events
(11%) could not be classiﬁed because of excessive noise.
3.5. ECG recordings detected automatically by ELR AUTO
Fig. 2 shows an analysis of a total of 5728 recordings obtained
by the ELR-AUTO automatically. Each recording was conﬁrmed and
classiﬁed by a specialized doctor. Of the 5728 recordings, 2374
(42%) were noise, 1445 (25%) were AF, 1349 (24%) were PACs, 270
(5%) were PVCs, 251 (4%) were missed beats, 16 (0.27%) were
pauses, 15 (0.26%) were bradycardias, 4 (0.06%) were supraven-
tricular tachycardias, and 4 (0.06%) were ventricular tachycardias.
3.6. Number of AF episodes per day
A total of 1492 AF episodes were recorded by the ELR-AUTO in 20
patients. Fig. 3 shows the incidence of AF for each day during the
ELR-AUTO monitoring period. The blue bar indicates the number
of AF episodes recorded by patient activation, while the red bar
indicates the number of episodes recorded automatically. Forty-
seven of the 1492 episodes (3.2%) recorded were symptomatic AF.
Table 3
Symptomatic and asymptomatic atrial ﬁbrillation.
ERþsymptomþ ERþsymptom p-Value
Patients (male/female) (n) 10 (9/1) 10 (7/3) NS
Age (years) 59.4713.8 63.478.0 NS
Disease duration (years) 6.173.6 2.272.1 0.01
Echocardiography
Left atrial diameter (mm) 46.277.9 42.775.0 NS
Left ventricular ejection fraction
(%)
61.779.3 62.874.9 NS
DcT (ms) 197.8768.4 234.0771.0 NS
E/e0 7.071.1 5.571.0 0.01
Antiarrhythmic drug (n) 7 5 NS
Underlying disease
HT (n) 4 7 NS
DM (n) 1 2 NS
Dyslipidemia (n) 1 5 0.04
CHF (n) 0 2 NS
ER: early recurrence, ERþsymptomþ: symptomatic and asymptomatic recurrent
AF group, ERþsymptom: asymptomatic recurrent AF groups, and NS: non-
signiﬁcant. Other abbreviations are as in Table 2.
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Fig. 1. The events for which patients activated the ELR-AUTO. There were a total of
393 events. This chart shows the ratio of events recorded when the patients felt
symptoms. A total of 393 events were detected, and among those associated with
subjective symptoms, the patients experienced the following: 177 events (45%) of
sinus rhythm, 125 events (31%) of a combination of atrial premature contractions
and premature ventricular contractions, 47 events (12%) of atrial ﬁbrillation, and 43
events (11%) of recording failure. AF: atrial ﬁbrillation, MB: missed beats, NSR:
normal sinus rhythm, PAC: premature atrial contractions, and PVC: premature
ventricular contractions.
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Fig. 2. The ECG recordings that were detected automatically by ELR-AUTO. This
graph shows the ratio of asymptomatic events detected automatically. There were a
total of 5728 events, of which 1445 (25%) were atrial ﬁbrillation. Additionally, 1349
events (24%) were premature atrial contractions, and 2374 events (42%) were
recording failures. NSVT: non-sustained ventricular tachycardia and SVT: sustained
ventricular tachycardia. Other abbreviations are as in Fig. 1.
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3.7. Early AF and late symptomatic AF
Fig. 4 shows the results of the long-term follow-up of the
recurrent (n¼20) and non-recurrent (n¼33) AF groups. There was
no signiﬁcant difference between the groups with regard to age,
disease duration, echocardiographic ﬁndings, underlying disease, or
late recurrence; however, there was a signiﬁcantly lower incidence
of late recurrence in patients who had no early recurrence.
Table 4 shows the characteristics of the late recurrent and non-
late recurrent AF groups. There was no signiﬁcant difference
between the groups with regard to age, disease duration, or
underlying disease; however, in patients without any late recur-
rence, the left atrial diameter was signiﬁcantly smaller, and the
male/female ratio was signiﬁcantly lower. Late recurrence occurred
in a signiﬁcantly greater number of patients who had experienced
AF recurrence within 3 months after PVI (8 patients; 20%) than in
those who had not. Seven of the 20 patients (35%) who had
experienced AF within 3 months after PVI had symptomatic AF
recurrence at 12 months. The sensitivity, speciﬁcity, positive pre-
dictive value, and negative predictive of early AF recurrence for late
recurrence were 87.5%, 71.1%, 35.0%, and 96.9%, respectively.
3.8. The incidence of AF recurrence for each month
The incidence of AF recurrence detected by ELR-AUTO for each
month after PVI is shown in Fig. 5. The incidence of patients with
early or late recurrence did not differ signiﬁcantly among the
months when ELA-AUTO recording was performed.
4. Discussion
4.1. Main ﬁndings
Most of the AF burden was asymptomatic. Freedom from AF in
the ﬁrst 3 months following PVI predicts long-term AF freedom.
4.2. AF recurrence within 3 months after PVI
To our knowledge, there are no previous reports that evaluated the
recurrence of AF within 3 months after PVI using ELR-AUTO. Previous
trials have reported AF recurrence rates of 35–65% within 3 months
after PVI [1,4–7]. Several recording systems, such as the Holter ECG,
event recorder, trans-telephonic monitoring, external loop recorder,
or implantable loop recorder (ILR), were used to identify AF recur-
rence in those studies. We could not compare the results of those
trials because of differences in the types of patients, ablation
strategies, deﬁnitions of recurrence, and ECG monitoring. However,
with longer monitoring times, the detection rate of AF recurrence
increased. In addition, continuous monitoring is necessary to detect
AF recurrence, because most AFs after PVI were asymptomatic.
A few studies reported that incomplete PVI was a predictor of
recurrence [2,8]. Only 2 patients had incomplete isolation in this
study, but they did not have early or late AF recurrence. It is
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Fig. 3. Number of episodes of atrial ﬁbrillation each day. The total number of
events per day in which a recurrence of paroxysmal atrial ﬁbrillation was observed.
PA: patient activated and AT: auto-trigger.
Fig. 4. Results of long-term follow-up. Late recurrence occurred in a signiﬁcantly higher number of patients who had experienced recurrence of atrial ﬁbrillation (AF) within
3 months after pulmonary vein isolation (8 patients; 20%) than in those who had not. Seven of the 20 patients (35%) who experienced AF within the 3 months had
symptomatic AF recurrence at 12 months. ER: early recurrence and LR: late recurrence.
Table 4
Late recurrence.
LRþ LR p-Value
Patients (male/female) (n) 8 (8/0) 45 (33/12) 0.003
Age (years) 61.676.9 61.6713.5 NS
Disease duration (years) 6.174.2 4.774.6 NS
Echocardiography
Left atrial diameter (mm) 47.676.3 42.975.9 0.04
Left ventricular ejection fraction (%) 59.276.8 61.575.8 NS
DcT (ms) 204.0749.6 220.8762.3 NS
E/e0 5.771.2 7.676.5 NS
Antiarrhythmic drug (n) 5 22 NS
Underlying disease
HT (n) 5 18 NS
DM (n) 1 4 NS
Dyslipidemia (n) 2 14 NS
CHF (n) 1 8 NS
LR: late recurrence. Other abbreviations are as in Tables 2 and 3.
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probable that a unidirectional block contributes to the suppression
of the trigger and perpetuation of AF, and that PVI causes local
denervation of the ganglionic plexus around the superior PV left
atrial junctions during the ablation procedure [9].
4.3. Symptomatic and asymptomatic AF
In the present study, the presence or absence of symptoms
during AF recurrence was examined. The symptomatic recurrence
group had a signiﬁcantly longer disease duration and higher E/e0
compared to the asymptomatic AF recurrence group. E/e0 reﬂects
diastolic dysfunction. Kosiuk et al. reported that diastolic dysfunc-
tion was correlated with symptom severity in AF [10]. A possible
explanation for that observation is a strong dependence of the
hemodynamic performance of the whole system on intact atrial
function, because the functional reserve of the impaired left
ventricle is greatly reduced during AF.
Neumann et al. also examined the detection of AF by symptoms
using a portable ECG event recorder in patients who underwent
PVI; they found that the detection of AF based on symptoms was
inaccurate [5]. Using ILR evaluation, Verma et al. found that the
incidence of asymptomatic AF before PVI was 52.0%; however, the
incidence of asymptomatic AF increased to 79.0% after PVI. After
PVI, the number and duration of AF episodes were decreased, as
was heart rate variability [11]. In this study, the incidence of
asymptomatic AF was 97%; therefore, we concluded that the
recurrence of AF after PVI could not be evaluated on the basis of
patient-reported symptoms.
4.4. Early recurrence and late recurrence
In the present study, it was hypothesized that patients with
early AF recurrences would have a signiﬁcant trend toward late AF
recurrences. Oral et al. and Joshi et al. reported that AF recurrence
2 weeks after ablation was a predictor of late phase recurrences
[1,3]. In addition, Joshi et al. reported that AF recurrence from
2 weeks to less than 3 months was not related to late recurrence.
On the other hand, Choi et al. reported that early recurrence
within 3 months after PVI was associated with late recurrence
[12]. In those studies, early recurrence was correlated with late
recurrence. In this study, the result was similar; however, the
positive predictive value was very low, and the negative predictive
value was high. This ﬁnding is promising. Freedom from atrial
ﬁbrillation in the ﬁrst 3 months following PVI predicts long-term
AF freedom. Because most AF episodes were asymptomatic, the
auto-trigger function of the ELR-AUTO was useful [1,3–7].
4.5. Usefulness of ELR-AUTO for identifying AF recurrence
Currently, Holter and trans-telephonic monitoring are the main
modalities for the identiﬁcation of arrhythmia recurrence. How-
ever, Ziegler et al. reported that intermittent and symptom-based
monitoring had lower sensitivity and a lower negative predictive
value for the identiﬁcation of patients with AF, and underesti-
mated the AF burden compared with continuous monitoring [13].
Verma et al. used ILRs to evaluate AF recurrence after PV isolation
and reported that the proportion of asymptomatic events
increased after PV isolation [10]. Kapa et al. used ILRs after
catheter ablation to investigate early and late AF recurrence [7].
They reported that the rate of AF recurrence was 47% from 1 to 6
months and 18% from 6 to 12 months [7]. Reiffel et al. investigated
the Holter ECG, ELRs, and automatic detection function ELRs, and
reported that the auto-detection ELRs were useful for the detec-
tion of asymptomatic arrhythmias [14]. Continuous monitoring is
necessary to identify AF recurrence. Martinez et al. also reported
the usefulness of the ELR for arrhythmia diagnoses [15]. There are
also reports that asymptomatic events increase after PVI, and it is
thought that an ELR-AUTO with an automatic detection function
would be useful for the evaluation of AF events after PVI ablation.
4.6. Incidence of AF recurrence for each of the ﬁrst 3 months
It would be extremely useful to know the best timing for
performing ECG monitoring within the ﬁrst 3 months (1 month,
2 months, or 3 months after PVI) for predicting long-term AF
recurrence. In this study, no optimal timing of ELR-AUTO monitor-
ing could be determined, because no signiﬁcant relationship was
found between the month within which early recurrence was
detected after PVI and late recurrence.
4.7. Limitations
This was a retrospective study, and the number of cases was
small. Some recordings could not be analyzed because of the level
of noise. The physicians and laboratory technicians conﬁrmed all
of the waveforms. In addition, the algorithm for the detection of an
irregular RR interval with ELR-AUTO has not been published.
Therefore, some AF episodes might have been missed. In addition,
the recurrence rate of atrial tachyarrhythmias with a regular
ventricular response under 160 beats/min would be underesti-
mated, because this ELR-AUTO did not detect them.
5. Conclusion
AF recurrence within 3 months after PVI can predict the
response to catheter ablation at 12 months. Freedom from AF in
the ﬁrst 3 months following ablation signiﬁcantly predicts long-
term AF freedom. ELR-AUTO is useful for the detection of sympto-
matic AF and asymptomatic AF.
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Fig. 5. The incidence of AF recurrence for each month. The incidence of AF
recurrence detected by ELR-AUTO for each month after pulmonary vein ablation
is shown. The incidence of patients with early or late recurrence did not differ
signiﬁcantly among the months when ELA-AUTO was performed. ER: early
recurrence and LR: late recurrence.
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